Clinical Trials
68 trialsMulti-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions
Azienda Sanitaria-Universitaria Integrata di Udine
Local and Peripheral Immune Responsive Landscape Induced by Local Cryoablation in Patients With Lung Adenocarcinoma
China-Japan Friendship Hospital
AMT-151 in Patients With Selected Advanced Solid Tumours
Multitude Therapeutics Inc.
Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1015)
Fudan University
Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1016)
Fudan University
ECTOP-1004
Fudan University
Early Detection of Lung Cancer With Machine Learning Based on Routine Clinical Investigations
The University Clinic of Pulmonary and Allergic Diseases Golnik
A Single-arm Exploratory Study of Neoadjuvant Therapy
Guangzhou Institute of Respiratory Disease
Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China
Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma
Fujian Cancer Hospital
Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma
Hunan Cancer Hospital
LungCaMa3D
Aristotle University Of Thessaloniki
Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study
Konkuk University Medical Center
Radiomics Combined With Frozen Section Prediction Model for Spread Through Air Space in Lung Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Exhaled Breath Particles in Lung Cancer
Lund University Hospital
The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer.
National Taiwan University Hospital
Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung
Sohag University
OS-TUMOVASC
Central Hospital, Nancy, France
ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas
Peking University People's Hospital
Identify Prognostic Biomarkers of Lung Cancer
RenJi Hospital
Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT)
Tianjin Medical University Cancer Institute and Hospital
TACTICAL
University College, London
The Impact of Polynuclear Neutrophils' Intra-tumoral Rate and the Mutational Status in Pulmonary Adenocarcinomas on Survival
Central Hospital, Nancy, France
Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis
Peking University People's Hospital
Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor Than 4 cm
Samsung Medical Center
PIONEER
SpeciCare
Derivation and Validation of a Scoring System to Distinguish Cryptococcosis and Adenocarcinoma in Pulmonary Nodules
Shanghai Pulmonary Hospital, Shanghai, China
TCM in the Treatment of Lung Adenocarcinoma
Henan University of Traditional Chinese Medicine
Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation
Henan Cancer Hospital
Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene
Sun Yat-sen University
The Tracking Molecular Evolution for NSCLC (T-MENC) Study
Geneplus-Beijing Co. Ltd.
Geber
Fujian Cancer Hospital
Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma
Henan Cancer Hospital
Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma
The University of Hong Kong
Benefit
Peking University Cancer Hospital & Institute
Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy
First People's Hospital of Hangzhou
CTCs detection
Third Military Medical University
Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial
Shanghai Chest Hospital
ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC
First People's Hospital of Hangzhou
NOTCH
University Hospital, Montpellier
LUNG-EST
Hospices Civils de Lyon
Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma
Anhui Provincial Hospital
A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy
First People's Hospital of Hangzhou
A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test
Southwest Hospital, China
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2
People's Hospital of Guangxi Zhuang Autonomous Region
Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma
Hunan Province Tumor Hospital
Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Capital Medical University
Telomere Biology in Early Adenocarcinoma of the Lung
Meir Medical Center